Found: 52
Select item for more details and to access through your institution.
Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer.
- Published in:
- Journal of Extracellular Vesicles, 2021, v. 10, n. 10, p. 1, doi. 10.1002/jev2.12136
- By:
- Publication type:
- Article
Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer.
- Published in:
- Clinical Genitourinary Cancer, 2024, v. 22, n. 5, p. N.PAG, doi. 10.1016/j.clgc.2024.102147
- By:
- Publication type:
- Article
Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 16, p. 3951, doi. 10.3390/ijms20163951
- By:
- Publication type:
- Article
Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 1, p. 104, doi. 10.3390/ijms18010104
- By:
- Publication type:
- Article
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 1, p. 57, doi. 10.1007/s10549-019-05365-y
- By:
- Publication type:
- Article
Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus viremia, the new surrogate marker of immune competence.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 2, p. 491, doi. 10.1002/jmv.25488
- By:
- Publication type:
- Article
Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment.
- Published in:
- Stem Cells Translational Medicine, 2018, v. 7, n. 3, p. 305, doi. 10.1002/sctm.17-0175
- By:
- Publication type:
- Article
β3-adREnoceptor Analysis in CORD Blood of Neonates (β3 RECORD): Study Protocol of a Pilot Clinical Investigation.
- Published in:
- Life (2075-1729), 2024, v. 14, n. 6, p. 776, doi. 10.3390/life14060776
- By:
- Publication type:
- Article
Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1307545
- By:
- Publication type:
- Article
Radiomics and liquid biopsy in oncology: the holons of systems medicine.
- Published in:
- Insights into Imaging, 2018, v. 9, n. 6, p. 915, doi. 10.1007/s13244-018-0657-7
- By:
- Publication type:
- Article
Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm.
- Published in:
- Oncology Reviews, 2020, v. 14, n. 2, p. 135, doi. 10.4081/oncol.2020.490
- By:
- Publication type:
- Article
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib Treatment.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Response to Wirostko et al. Re: "Cross-Linked Hyaluronic Acid as Tear Film Substitute" by Posarelli et al. ( 2019;35(7):381-387).
- Published in:
- 2020
- By:
- Publication type:
- Letter
Cross-Linked Hyaluronic Acid as Tear Film Substitute.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 6, p. 1667, doi. 10.1007/s00262-020-02810-6
- By:
- Publication type:
- Article
Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Cost-Effectiveness of Treatment Optimisation with Biomarkers for Immunotherapy in Solid Tumours: A Systematic Review.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 995, doi. 10.3390/cancers16050995
- By:
- Publication type:
- Article
CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1306, doi. 10.3390/cancers15041306
- By:
- Publication type:
- Article
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2435, doi. 10.3390/cancers14102435
- By:
- Publication type:
- Article
The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092104
- By:
- Publication type:
- Article
A Real-World Application of Liquid Biopsy in Metastatic Colorectal Cancer: The Poseidon Study.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5128, doi. 10.3390/cancers13205128
- By:
- Publication type:
- Article
Gemcitabine Plus Nab-Paclitaxel Induces PD-L1 mRNA Expression in Plasma-Derived Microvesicles in Pancreatic Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3738, doi. 10.3390/cancers13153738
- By:
- Publication type:
- Article
Liquid Biopsies from Pleural Effusions and Plasma from Patients with Malignant Pleural Mesothelioma: A Feasibility Study.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2445, doi. 10.3390/cancers13102445
- By:
- Publication type:
- Article
Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 771, doi. 10.3390/cancers13040771
- By:
- Publication type:
- Article
Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 1, p. 57, doi. 10.1002/1878-0261.12827
- By:
- Publication type:
- Article
IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-023-11726-0
- By:
- Publication type:
- Article
Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.674604
- By:
- Publication type:
- Article
Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.593831
- By:
- Publication type:
- Article
Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1134436
- By:
- Publication type:
- Article
Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 12, p. 1610, doi. 10.1093/neuonc/noz157
- By:
- Publication type:
- Article
Recurrent USP6 rearrangement in a subset of atypical myofibroblastic tumours of the soft tissues: low‐grade myofibroblastic sarcoma or atypical/malignant nodular fasciitis?
- Published in:
- Histopathology, 2024, v. 85, n. 2, p. 244, doi. 10.1111/his.15196
- By:
- Publication type:
- Article
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia.
- Published in:
- Frontiers in Pharmacology, 2016, v. 7, p. 1, doi. 10.3389/fphar.2016.00363
- By:
- Publication type:
- Article
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response.
- Published in:
- 2018
- By:
- Publication type:
- journal article
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report.
- Published in:
- 2019
- By:
- Publication type:
- journal article
CYP17A1 polymorphism c.-362T>C predicts clinical outcome in metastatic castration-resistance prostate cancer patients treated with abiraterone.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 4, p. 527, doi. 10.1007/s00280-020-04133-w
- By:
- Publication type:
- Article
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Androgen receptor (AR) splice variant 7 and full‐length AR expression is associated with clinical outcome: a translational study in patients with castrate‐resistant prostate cancer.
- Published in:
- BJU International, 2019, v. 124, n. 4, p. 693, doi. 10.1111/bju.14792
- By:
- Publication type:
- Article
ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00547
- By:
- Publication type:
- Article
Dihydropyrimidine dehydrogenase deficiency in patients with severe toxicity after 5-fluorouracil: a retrospective single-center study.
- Published in:
- Annals of Gastroenterology, 2021, v. 34, n. 1, p. 68, doi. 10.20524/aog.2020.0551
- By:
- Publication type:
- Article
eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial.
- Published in:
- Journal of Translational Medicine, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12967-015-0619-5
- By:
- Publication type:
- Article
eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 6, p. 1305, doi. 10.3390/diagnostics12061305
- By:
- Publication type:
- Article
TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma.
- Published in:
- Frontiers in Molecular Biosciences, 2024, p. 01, doi. 10.3389/fmolb.2024.1288677
- By:
- Publication type:
- Article
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.824511
- By:
- Publication type:
- Article
Exploring the epigenetic susceptibility mechanisms of lung cancer through DNA methylation markers.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 6, p. 848, doi. 10.1002/cncr.35203
- By:
- Publication type:
- Article